Pharmacokinetic Interaction of Favipiravir with Citalopram and Pioglitazone
The current study's objective was to investigate the interactions of favipiravir with pioglitazone and citalopram. 25 Spraque-Dawley female rats were used in the study. Rats in groups 1 and 4 were given pioglitazone (1 mg/kg/day) for 7 days and rats in groups 2 and 5 were given citalopram (1.5...
Saved in:
Main Authors: | Zeliha Keskin Alkaç (Author), Dilan Aşkın Özek (Author), Hande Yüce (Author), Fatih Ahmet Korkak (Author), Sümeyye Aslan (Author), Neşe Başak Türkmen (Author), Songül Ünüvar (Author) |
---|---|
Format: | Book |
Published: |
Krupanidhi College of Pharmacy,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
18β-glycyrrhetinic acid attenuates global cerebral ischemia/reperfusion-induced cardiac damage in C57BL/J6 mice
by: Neşe Başak Türkmen, et al.
Published: (2023) -
Diplopia; an Adverse Effect of Citalopram
by: Seyed Hamzeh Hosseini, et al.
Published: (2019) -
Population pharmacokinetics of favipiravir in patients with COVID‐19
by: Kei Irie, et al.
Published: (2021) -
Citalopram intoxication in four week old infant
by: Jo-Anne Janson, et al.
Published: (2020) -
A Síndrome do QT Longo Associada ao uso de Citalopram e Escitalopram / The Long QT Syndrome Associated to Citalopram and Escitalopram
by: Filipe Santos Falani, et al.
Published: (2016)